These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21254338)

  • 21. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 22. Understanding cardiovascular biomarkers.
    Hieronymus L; Wortzman-Show G
    Diabetes Self Manag; 2013; 30(3):16, 18-20. PubMed ID: 23951629
    [No Abstract]   [Full Text] [Related]  

  • 23. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of high-sensitivity C-reactive protein].
    Ueno H
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():137-41. PubMed ID: 16983765
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation.
    Lund J; Qin QP; Ilva T; Pettersson K; Voipio-Pulkki LM; Porela P; Pulkki K
    Circulation; 2003 Oct; 108(16):1924-6. PubMed ID: 14530192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging in haemophilia: getting to the heart of the matter.
    Ragni MV
    Thromb Haemost; 2011 Feb; 105(2):207-8. PubMed ID: 21225103
    [No Abstract]   [Full Text] [Related]  

  • 27. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
    Blankenberg S; Yusuf S
    Circulation; 2006 Oct; 114(15):1557-60. PubMed ID: 17030701
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management.
    Desai S; Hong JC; Saab S
    Liver Int; 2010 Aug; 30(7):948-57. PubMed ID: 20500807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.
    Gravning J; Ueland T; Mørkrid L; Endresen K; Aaberge L; Kjekshus J
    Scand Cardiovasc J; 2008 Jun; 42(3):214-21. PubMed ID: 18569954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

  • 32. [Emerging risk factors for cardiovascular disease].
    Demant T
    Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418
    [No Abstract]   [Full Text] [Related]  

  • 33. [The revival of an old diagnostic marker: C-reactive protein].
    Sela B
    Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list.
    Roberts MA; MacMillan N; Hare DL; Ratnaike S; Sikaris K; Fraenkel MB; Ierino FL
    Nephrology (Carlton); 2006 Oct; 11(5):471-6. PubMed ID: 17014564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data are cumulating about elevated troponin I levels in asymptomatic dialysis patients.
    Afsar B; Elsurer R
    Nephrol Dial Transplant; 2011 Mar; 26(3):1111-2; author reply 112. PubMed ID: 21189292
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].
    Sinning C; Keller T; Blankenberg S
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2019-22. PubMed ID: 19777420
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
    Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Bertomeu V; Pellicer M; Chorro FJ
    Int J Cardiol; 2005 Feb; 98(2):277-83. PubMed ID: 15686779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation.
    Bianchi G; Nicolino F; Passerini G; Grazi GL; Zappoli P; Graziani R; Berzigotti A; Chianese R; Mantovani V; Pinna AD; Zoli M
    Liver Transpl; 2006 Jan; 12(1):105-11. PubMed ID: 16382457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there disparity between risk and incidence of cardiovascular disease after liver transplant?
    Neal DA; Tom BD; Luan J; Wareham NJ; Gimson AE; Delriviere LD; Byrne CD; Alexander GJ
    Transplantation; 2004 Jan; 77(1):93-9. PubMed ID: 14724441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.